Acarix

About:

Acarix is a medical startup focused on the acoustic monitoring of coronary artery diseases of the heart.

Website: http://acarix.com

Top Investors: Seventure Partners, Seed Capital, Sunstone Life Science Ventures, Puhua Jingxin Guzhou Health

Description:

Acarix A/S is based on pioneering research performed at the Aalborg University, Denmark, initiated in 2004. The research group received the award, ‘MedicoPrisen’, from Medicoindustrien (Danish Medtech trade association) in 2007. A research and development collaboration was established in 2007 between Aalborg University and Coloplast A/S, receiving public support from the Danish National Advanced Technology Foundation in 2008. Acarix A/S was established in 2009 as a spin-out company from Coloplast A/S with Coloplast A/S and Aalborg University as the major shareholders. In 2010 Acarix A/S succeeded attracting venture capital from Seed Capital (DK), Sunstone Capital (DK) and Seventure Partners (F). In 2011 Acarix A/S and collaborators furthermore achieved funding of 5.3 million DKK from the Danish Business Innovation Fund.

Total Funding Amount:

$10.7M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Kongens Lyngby, Hovedstaden, Denmark

Founded Date:

2009-01-01

Contact Email:

dkps(AT)acarix.com

Founders:

Claus Bo Vöge Christensen, Peter Samuelsen

Number of Employees:

1-10

Last Funding Date:

2016-11-11

IPO Status:

Public

Industries:

© 2025 bioDAO.ai